https://www.truveta.com/blog/abstract/ 2025-02-03T22:26:21+00:00 https://www.truveta.com/research/abstract/access-to-anti-obesity-glp-1s-for-medicare-aged-adults/ 2025-02-03T22:14:29+00:00 https://www.truveta.com/wp-content/uploads/2024/03/Access-to-GLP-1s-for-Medicare-aged-adults92.png https://www.truveta.com/research/abstract/baseline-a1c-and-bmi-trends-for-people-with-type-2-diabetes-receiving-first-time-glp-1-ra-prescriptions/ 2025-02-03T22:14:36+00:00 https://www.truveta.com/wp-content/uploads/2024/05/A1C-values-prior-to-GLP1-RA-initiation-by-income-group.jpeg https://www.truveta.com/research/abstract/cannabis-related-emergency-department-visits-from-2019-2023/ 2025-02-03T22:14:39+00:00 https://www.truveta.com/wp-content/uploads/2024/01/cannabis_induced_disorders-1.jpg https://www.truveta.com/research/abstract/exploring-medication-switching-trends-from-humira-to-approved-biosimilars/ 2025-02-03T22:14:43+00:00 https://www.truveta.com/wp-content/uploads/2024/08/time_trend.jpg https://www.truveta.com/research/abstract/removing-race-from-ckd-diagnostic-criteria/ 2025-02-03T22:14:47+00:00 https://www.truveta.com/wp-content/uploads/2024/08/Patient-Selection-Time-1.jpg https://www.truveta.com/research/abstract/monitoring-report-glp-1-ra-prescribing-trends/ 2025-02-03T22:14:51+00:00 https://www.truveta.com/wp-content/uploads/2024/10/Real-time-monitoring-of-GLP-1-RA-medications-102463.jpg https://www.truveta.com/research/abstract/monitoring-report-viral-gastroenteritis-april-data/ 2025-02-03T22:14:55+00:00 https://www.truveta.com/wp-content/uploads/2024/05/Thumbnail-Real-time-monitoring-of-viral-gastroenteritis.jpg https://www.truveta.com/research/abstract/real-world-patterns-in-glp-1-ra-switching-from-2018-2023-in-the-us/ 2025-02-03T22:15:00+00:00 https://www.truveta.com/wp-content/uploads/2024/08/Sankey_overall-2.jpg https://www.truveta.com/research/abstract/real-world-prescribing-of-lecanemab-in-the-united-states/ 2025-02-03T22:15:05+00:00 https://www.truveta.com/wp-content/uploads/2024/04/lecanemab_first_time.jpg https://www.truveta.com/research/abstract/semaglutide-vs-tirzepatide-for-weight-loss-in-adults-with-overweight-or-obesity/ 2025-02-03T22:15:08+00:00 https://www.truveta.com/wp-content/uploads/2024/07/5kxuz2ad.png https://www.truveta.com/research/abstract/sports-injuries-by-the-numbers-the-most-common-sports-injuries-in-basketball/ 2025-02-03T22:15:13+00:00 https://www.truveta.com/wp-content/uploads/2023/03/Body_part_affected_Basketball.jpg https://www.truveta.com/research/abstract/the-adderall-shortage-exploring-rates-of-prescription-fills-over-time/ 2025-02-03T22:15:17+00:00 https://www.truveta.com/wp-content/uploads/2024/04/fill_rate_overall.jpg https://www.truveta.com/research/abstract/trends-in-psa-testing-to-screen-for-prostate-related-conditions-including-cancer/ 2025-02-03T22:15:22+00:00 https://www.truveta.com/wp-content/uploads/2024/06/PSA_value_byage_hist.jpg https://www.truveta.com/research/abstract/trends-in-winter-falls-and-associated-injuries/ 2025-02-03T22:15:27+00:00 https://www.truveta.com/wp-content/uploads/2024/02/Injury_rate.jpg https://www.truveta.com/research/abstract/using-echocardiogram-data-to-classify-aortic-stenosis-severity-subsequent-procedures-and-disparities/ 2025-02-03T22:15:30+00:00 https://www.truveta.com/wp-content/uploads/2024/03/Echo-Blog-Flow-chart-Truveta.jpg https://www.truveta.com/research/abstract/adderall-shortage-exploring-first-time-adhd-diagnoses-and-adderall-prescriptions/ 2025-02-03T22:26:21+00:00 https://www.truveta.com/wp-content/uploads/2024/12/ADHD_diagnosis_overall_stat.jpg